Molecular Vision: Nassiri, Mol Vis 2012; 18:1991-1995. Table 2

Table 2. Aqueous level of erythropoietin (mIU/ml) in the control group, and glaucomatous eyes with controlled and uncontrolled intraocular pressure.

	Eyes with controlled IOP (≤target pressure)			Eyes with uncontrolled IOP (>target pressure)
Groups	N	IOP (Mean±SD)	EPO (Mean±SE)	N	IOP (Mean±SD)	EPO (Mean±SE)	p-value**
Control	26	12.6±1.5	0.8±5.4	—	—	—	—
POAG	27	14.1±3.6	14.8±6.3*	13	28.7±6.5	20.4±6.3*	0.147
PXFG	15	14.5±3.7	4.7±1.5*	11	31.5±12.2	28.2±13.9*	0.256
NVG	17	15.1±4.6	108.1±40.5*	9	32.3±11.1	168.2±39.8*	0.516

*Statistically significantly higher compared to the control group using Mann–Whitney U test (p<0.05); Target pressure: upper limit of intraocular pressure that prevents further glaucomatous damage; **Mann–Whitney U test was used for analysis, as the aqueous level of erythropoietin was not normally distributed. IOP: intraocular pressure; EPO: erythropoietin; POAG: primary open angle glaucoma; NVG: neovascular glaucoma; PXFG: pseudoexfoliative glaucoma.